
Zydus Lifesciences Limited has informed the Exchange about press release dated 26-Apr-2022 titled ZyCoV-D as a two-dose vaccine receives EUA from DCGI
Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange about press release dated 26-Apr-2022 titled ZyCoV-D as a two-dose vaccine receives EUA from DCGI
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences